Poland - Dąbrowa Górnicza: Pharmaceutical products

Release

ID
ocds-pyfy63:2023-517194:2023-517194
Date
2023-08-28
Language
PL
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2023-517194

Releases in JSON

Tender

Title
Poland - Dąbrowa Górnicza: Pharmaceutical products
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price
Award period
2023-09-25 - ?
Eligibility criteria
Suitability:

O udzielenie zamówienia mogą ubiegać się wykonawcy, którzy spełniają warunki udziału w postępowaniu, dotyczące uprawnień do prowadzenia określonej działalności gospodarczej lub zawodowej, o ile wynika to z odrębnych przepisów: Wykonawca spełni warunek udziału w postępowaniu dotyczący kompetencji lub uprawnień do prowadzenia określonej działalności zawodowej jeżeli wykaże, że posiada zezwolenie na obrót produktami leczniczymi zgodnie z ustawą z dnia 6 września 2001 roku Prawo farmaceutyczne – tj. zezwolenie (Decyzja) Głównego Inspektora Farmaceutycznego na prowadzenie hurtowni farmaceutycznej lub zezwolenie w zakresie obrotu hurtowego, udzielone przez właściwy organ państwa, na terenie którego dany podmiot ma siedzibę (dotyczy państwa członkowskiego UE lub państwa członkowskiego EFTA - strony umowy o EOG).- w przypadku gdy wykonawca jest wytwórcą zezwolenie Głównego Inspektora Farmaceutycznego na wytwarzanie produktów leczniczych zgodnie z ustawą Prawo Farmaceutyczne z dnia 6 września 2001 r.
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2023-08-28 - 2023-09-25

Tender item

ID
ocds-pyfy63:2023-517194:obj:1
Classification
CPV / 33600000
Description
Cetuximabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:2
Classification
CPV / 33600000
Description
Panitumumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:3
Classification
CPV / 33600000
Description
Apalutamid

Tender item

ID
ocds-pyfy63:2023-517194:obj:4
Classification
CPV / 33600000
Description
Aflibercept

Tender item

ID
ocds-pyfy63:2023-517194:obj:5
Classification
CPV / 33600000
Description
Erlotynib

Tender item

ID
ocds-pyfy63:2023-517194:obj:6
Classification
CPV / 33600000
Description
Gefytynibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:7
Classification
CPV / 33600000
Description
Osimertinibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:8
Classification
CPV / 33600000
Description
Crizotynibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:9
Classification
CPV / 33600000
Description
Pembrolizumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:10
Classification
CPV / 33600000
Description
Nivolumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:11
Classification
CPV / 33600000
Description
Afatinib

Tender item

ID
ocds-pyfy63:2023-517194:obj:12
Classification
CPV / 33600000
Description
Nintedanibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:13
Classification
CPV / 33600000
Description
Trabectedinum

Tender item

ID
ocds-pyfy63:2023-517194:obj:14
Classification
CPV / 33600000
Description
Pazopanibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:15
Classification
CPV / 33600000
Description
Sunitinibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:16
Classification
CPV / 33600000
Description
Trastuzumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:17
Classification
CPV / 33600000
Description
Lapatynibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:18
Classification
CPV / 33600000
Description
Pertuzumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:19
Classification
CPV / 33600000
Description
Olaparibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:20
Classification
CPV / 33600000
Description
Trifluridinum + tipiracil

Tender item

ID
ocds-pyfy63:2023-517194:obj:21
Classification
CPV / 33600000
Description
Trastuzumabum emtansinum

Tender item

ID
ocds-pyfy63:2023-517194:obj:22
Classification
CPV / 33600000
Description
Enzalutamid

Tender item

ID
ocds-pyfy63:2023-517194:obj:23
Classification
CPV / 33600000
Description
Abirateron

Tender item

ID
ocds-pyfy63:2023-517194:obj:24
Classification
CPV / 33600000
Description
Alectinib

Tender item

ID
ocds-pyfy63:2023-517194:obj:25
Classification
CPV / 33600000
Description
Atezolizumab

Tender item

ID
ocds-pyfy63:2023-517194:obj:26
Classification
CPV / 33600000
Description
Ribociclib

Tender item

ID
ocds-pyfy63:2023-517194:obj:27
Classification
CPV / 33600000
Description
Palbociclib

Tender item

ID
ocds-pyfy63:2023-517194:obj:28
Classification
CPV / 33600000
Description
Trastuzumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:29
Classification
CPV / 33600000
Description
Lorlatinib

Tender item

ID
ocds-pyfy63:2023-517194:obj:30
Classification
CPV / 33600000
Description
Dacomitinib

Tender item

ID
ocds-pyfy63:2023-517194:obj:31
Classification
CPV / 33600000
Description
Brigatinib

Tender item

ID
ocds-pyfy63:2023-517194:obj:32
Classification
CPV / 33600000
Description
Durvalumab

Tender item

ID
ocds-pyfy63:2023-517194:obj:33
Classification
CPV / 33600000
Description
Abemacyclib

Tender item

ID
ocds-pyfy63:2023-517194:obj:34
Classification
CPV / 33600000
Description
Ceritinib

Tender item

ID
ocds-pyfy63:2023-517194:obj:35
Classification
CPV / 33600000
Description
Darolutamid

Tender item

ID
ocds-pyfy63:2023-517194:obj:36
Classification
CPV / 33600000
Description
Denosumab

Tender item

ID
ocds-pyfy63:2023-517194:obj:37
Classification
CPV / 33600000
Description
Paclitaxelum albuminatum

Tender item

ID
ocds-pyfy63:2023-517194:obj:38
Classification
CPV / 33600000
Description
Ipilimumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:39
Classification
CPV / 33600000
Description
Niraparibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:40
Classification
CPV / 33600000
Description
Entrectinibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:41
Classification
CPV / 33600000
Description
Imatinibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:42
Classification
CPV / 33600000
Description
Cabazitaxelum

Tender item

ID
ocds-pyfy63:2023-517194:obj:43
Classification
CPV / 33600000
Description
Larotrectinibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:44
Classification
CPV / 33600000
Description
Alpelisibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:45
Classification
CPV / 33600000
Description
Talazoparibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:46
Classification
CPV / 33600000
Description
Sacituzumabum govitecanum

Tender item

ID
ocds-pyfy63:2023-517194:obj:47
Classification
CPV / 33600000
Description
Avelumabum

Tender item

ID
ocds-pyfy63:2023-517194:obj:48
Classification
CPV / 33600000
Description
Tucatinibum

Tender item

ID
ocds-pyfy63:2023-517194:obj:49
Classification
CPV / 33600000
Description
Cemiplimabum

Parties

Roles
buyer
Organization name
Zagłębiowskie Centrum Onkologii Szpital Specjalistyczny im. Sz. Starkiewicza w Dabrowie Górniczej
Street address
ul. Szpitalna 13
Locality
Dąbrowa Górnicza
Postal code
41 - 300
Country
PL
E-mail
zamowienia.publiczne@zco-dg.pl
Phone
+32 6212050
Fax
+32 2623422
Website
www.zco-dg.pl

Organization data Organization in JSON